Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew Plc    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 01/19 10:24:16 am
1629.5 GBX   +3.82%
01/12European ADRs Move Higher in Tuesday Trading
MT
01/12SMITH & NEPHEW : +Nephew update on fourth quarter and full year 2020 trading
AQ
01/11European ADRs Move Sharply Lower in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Smith & Nephew : 3Q Underlying Revenue Improved After Virus Hit

10/29/2020 | 02:29am EST

By Matteo Castia

Smith & Nephew PLC said Thursday that third-quarter underlying revenue strongly recovered from the previous quarter's steep decline caused by the coronavirus pandemic, although it remained down year-on-year.

The FTSE-100 medical-technology group said quarterly underlying revenue, which strips out exceptional and other one-off items, fell 4.2% on the year, compared with 4% growth posted in the year-earlier period. This compares with a 29% underlying revenue fall in the second quarter.

At the beginning of this month, the company had guided for a 4% fall in underlying revenue for the third quarter, as its three franchises had been showing significant recovery during the period.

Revenue in the period fell 3.7% year-on-year to $1.2 billion.

Smith & Nephew said that growth in its Chinese and U.S. market has been offset by a continued hit from the pandemic in India and Latin America.

Write to Matteo Castia at matteo.castia@dowjones.com

(END) Dow Jones Newswires

10-29-20 0328ET

Stocks mentioned in the article
ChangeLast1st jan.
MSCI UNITED KINGDOM (STRD, UHD) -0.25% 1066.915 Real-time Quote.3.74%
SMITH & NEPHEW PLC 3.44% 1626.5 Delayed Quote.3.94%
All news about SMITH & NEPHEW PLC
01/12European ADRs Move Higher in Tuesday Trading
MT
01/12SMITH & NEPHEW : +Nephew update on fourth quarter and full year 2020 trading
AQ
01/11European ADRs Move Sharply Lower in Monday Trading
MT
01/11SMITH & NEPHEW : Warns of Revenue, Margin Hit for 2020
DJ
01/11SMITH & NEPHEW : Expects Q4, FY20 Revenue Drop On Lower Sales, Volumes Amid COVI..
MT
01/05SMITH & NEPHEW : Arthrex's Initial Merits Brief – Making The Case For Pate..
AQ
01/04SMITH & NEPHEW : Completes $240 Million Acquisition of Integra LifeSciences' Ext..
MT
01/04Smith & Nephew Plc Smith+Nephew Completes Orthopaedics Acquisition
DJ
01/04SMITH & NEPHEW : +Nephew completes Extremity Orthopaedics acquisition
PU
01/04SMITH & NEPHEW PLC : Acquisition
CO
More news
Financials (USD)
Sales 2020 4 590 M - -
Net income 2020 377 M - -
Net Debt 2020 1 638 M - -
P/E ratio 2020 52,2x
Yield 2020 1,33%
Capitalization 18 657 M 18 648 M -
EV / Sales 2020 4,42x
EV / Sales 2021 3,73x
Nbr of Employees 17 500
Free-Float 98,7%
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | SN. | GB0009223206 | MarketScreener
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 23,32 $
Last Close Price 21,32 $
Spread / Highest target 26,2%
Spread / Average Target 9,39%
Spread / Lowest Target -15,2%
EPS Revisions
Managers and Directors
NameTitle
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Roberto Quarta Chairman
Mark Gladwell President-Global Operations & Business Services
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors